Biotechnology Product Manufacturing Industry Profile

Report Page Length: 10-12
Last Quarterly Update: 1/24/2022
SIC Codes: 2836
NAICS Codes: 325414
Chapters Include:
Industry Overview Trends & Challenges Industry Forecast
Quarterly Industry Update Call Prep Questions Website & Media Links
Business Challenges Financial Information Glossary & Acronyms
View Full Sample Add To Cart

Excerpt from Biotechnology Product Manufacturing Industry Profile

Companies in this industry manufacture vaccines, toxoids, blood fractions, and culture media of plant or animal origin. Major companies include Amgen, Biogen, Genentech (owned by Switzerland-based Roche), and Gilead Sciences (all based in the US), as well as Bayer (Germany), CSL (Australia), Merck (Germany), Novo Nordisk (Denmark), and the biotech research arms of major international pharmaceutical companies such as Sanofi (France).

The global biotechnology industry generated a total revenue of about $83 billion in 2020 and is expected to reach about $135.9 billion by 2025, according to PR NewsWire. The top region for biotechnology is the US, followed by China, according to Statista. Other markets include Denmark, the Netherlands, South Korea, the UK, Switzerlan, and Taiwan, among others.

The US biotechnology product manufacturing industry generates annual revenue of about $30 billion and has about 350 establishments in the US. Because many drugs are now developed using biotechnology, the biotechnology and pharmaceutical industries overlap considerably. A separate industry report covers Pharmaceutical Manufacturing.

COMPETITIVE LANDSCAPE

Biotech firms face stiff competition from major pharmaceutical manufacturers and other companies seeking to be first with a new product or discovery. Development is often focused on high-demand, profitable markets such as cancer or rare disease treatment. Biopharmaceutical companies depend on gaining regulatory and insurance coverage approval for new treatments. They may also count on participation in government research or expedited approval programs.

Because the market for potential products is so ...

 
View Full Sample Add To Cart Return to the Industry Profile Menu

Would you or your company benefit from having unlimited access to First Research's industry intelligence tools?

Learn More About Subscription Options